Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
When a tech giant like Meta Platforms hints at neocloud moves, investors crave clarity. This article breaks down what...
When a big fund trims a REIT stake, investors watch for clues about rental income and stock performance. This article...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
A Vesta director recently sold roughly $203,000 worth of stock while the company’s shares have risen about 25% over t...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
D-Wave Quantum spiked on news of fresh government funding but ended lower as bulls and bears debated quantum advantag...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
Triata Capital's sizable stake reduction in GDS Holdings has traders and investors buzzing about AI data-center expos...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...